Original Research
Published on 21 Sep 2022
A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs
in Cancer Genetics and Oncogenomics
- 3,123 views
- 2 citations
Original Research
Published on 21 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 21 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 21 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 21 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 21 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 21 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 21 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 20 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 20 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 20 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 20 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 19 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 19 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 19 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 19 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 16 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 16 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 16 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 16 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 15 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 15 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 15 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 15 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 15 Sep 2022
in Cancer Genetics and Oncogenomics